Rie Ogawa

Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019

Emi Takashita, Chiharu Kawakami, Rie Ogawa et al. · Eurosurveillance · 2019 · 124 citations · Full text

Viral Evolution, Viral Diagnostics, Emerging Infectious Diseases +14

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Emi Takashita, Chiharu Kawakami, Hiroko Morita et al. · Eurosurveillance · 2019 · 106 citations · Full text

Viral Diagnostics, Antiviral Drug Development, Reduced Susceptibility +8

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019

Emi Takashita, Masataka Ichikawa, Hiroko Morita et al. · Emerging infectious diseases · 2019 · 103 citations · Full text

Vaccination, Viral Evolution, Pathogen Prevalence +14

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil

Emi Takashita, Hiroko Morita, Rie Ogawa et al. · Frontiers in Microbiology · 2018 · 96 citations · Full text

Reference Virus, Viral Diagnostics, Emerging Infectious Diseases +13

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir

Emi Takashita, Miho Ejima, Rie Ogawa et al. · Antiviral Research · 2016 · 70 citations · Full text

Favipiravir Administration, Pharmacology, Immunology +9